Literature DB >> 29556263

Identification of functional modules induced by bare-metal stents and paclitaxel-eluting stents in coronary heart disease.

Zhaobin Tang1, Jingjing Gu2, Ping Sun2, Jing Zhao3, Yonggang Zhao1.   

Abstract

Bare-metal stents (BMS) and paclitaxel-eluting stent (PES) are frequently used in medicine for the treatment of coronary heart disease, with millions of patients treated worldwide. The protein-protein interactions (PPI) were adopted to construct the networks. The M-module algorithm was used to identify multiple differential modules. Gene Ontology enrichment and pathway enrichment analysis were performed to analyze characteristics of modules. With the PPI and microarray data, two differential co-expressed networks were constructed, module 1 indicating PES and module 2 indicating BMS, with the same genes but different edges. At a module connectivity dynamic score P-value cut-off of <0.05, module 1 was identified with 142 nodes and 460 edges and in the module 2, 73 nodes and 222 edges were identified. Significant biological processes and pathways were found different in the two modules. Through the two differential modules, we revealed the potential molecular changes induced by PES and BMS providing new insights into the underlying mechanisms in human left internal mammary arteries after inserted with a stent.

Entities:  

Keywords:  bare-metal stents; left internal mammary artery arteries; module; paclitaxel-eluting stents; pathway

Year:  2018        PMID: 29556263      PMCID: PMC5844177          DOI: 10.3892/etm.2018.5879

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

The introduction of stent by Puel and Sigwart in clinical practice marked a new era in operational cardiology (1). Bare-metal stents (BMS) or drug-eluting stents (DES) are frequently used in medicine, with millions of patients treated worldwide (2,3). The use of DES has been shown more effective than BMS in the reduction of restenosis (4). In particular, paclitaxel-eluting stent (PES) has been shown remarkably effective compared with BMS. PES has been approved by the US Food and Drug Administration for treating coronary artery disease (CAD) (5), although it is now rarely used in the US and Europe due to the superiority of second-generation stents (zotarolimus and everolimus-eluting stents) (6). The purpose of this study was to compare the putative molecular mechanism induced by PES and BES in denuded human left internal mammary arteries (LIMA). Network biology has been applied to study cardiovascular diseases, such as coronary heart disease (7) atherosclerosis (8) and heart failure (9). Understanding the molecular networks may provide important insights into the effect of PES and BMS in LIMA. Several methods have been developed to construct gene regulator networks or modules, including Bayesian probabilistic network method (10), Genetic Network Expansion SYStem (11) and Minreg method (12). The iMDM algorithm is another method to identify both unique and shared gene modules across multiple differential co-expression networks (DCNs) (13). This method showed higher accuracy in inferring genes and modules compared with other method. In multiple conditions, the multiple differential modules (M-DMs) algorithm revealed dynamic changes in both gene activity and connectivity (13). To date, microarrays have been a powerful tool to analyze gene expression levels and gene functions (14). MicroRNA microarrays have been used to explore the role of miRNA in different pathophysiological states. miRNA expression was first used to construct networks to identify important miRNA cliques (15). Besides, miRNA microarray can be used to investigate functional links between miRNAs by analyzing conserved miRNA co-expression relationships (16). In the present study, we applied iMDM algorithm to analyze microarray data to compare molecular mechanism in LIMA induced by PES and BMS. We constructed DCNs by mapping genes to protein-protein interaction (PPI) data. The iMDM algorithm was used to identify differential modules. The Gene Ontology (GO) and pathway were applied for enrichment analysis. This method may provide new insights to the comparison of BMS and PES in LIMA.

Materials and methods

Datasets

Gene expression data

Microarray gene expression data of E-GEOD-19136 was obtained from ArrayExpress database. The data indicated gene expression response to the implantation of drug (paclitaxel)-eluting or BMS in denuded human LIMA. Human LIMA was divided into three segments and two of the segments were fitted with either a PES or a BMS. The data includes three groups, control (n=4), PES (n=4), and BMS (n=4). Gene expression profiling was generated from the platform of (HG-U133_Plus_2) Affymetrix Human Genome U133 Plus 2.0 Array. The title was ‘Gene expression response to implanted drug (paclitaxel)-eluting or BMS in denuded human LIMA’. All the referred experiment samples were obtained with informed consent of the patients and verified by the Ethics Committee of the First Hospital of Zibo (Shandong, China).

Data preprocessing

To eliminate influences of nonspecific hybridization, background was corrected with RMA (17). After data were normalized with ‘quantiles’ (18), PM/MM correction was conducted with MAS method (19), and medianpolish was conducted for summarizing data (20). According to the platform annotation files, probes were mapped to gene symbols. If more than one probe was mapped to a single gene, the mean level of probes was calculated as the final gene expression level. In total, 20,545 genes were obtained.

PPI network construction

PPI data were obtained from Search Tool for the Retrieval of Interacting Genes/Proteins database (http://string-db.org/) (21), including 15,186 genes and 181,789 interactions. We selected the PPI which contains the same genes with the microarray data for further analysis. In total, 14,194 genes and 166,370 PPI were obtained. After all the interactions were performed Pearson's correlation analysis, the edge with an absolute value more than δ (δ=0.95) was selected, including 16,813 edges and 4,504 nodes. These edges were used to construct DCNs. Thus, two modules were obtained, module 1 indicating PES and 2 indicating BMS group. They had the same genes in the networks. Each gene in the DCN was analyzed using one-sided t-test in the baseline and disease conditions. The weight was calculated using the following formula, where V indicates the node set in the network, pi and pj are P-values of differential expression for genes i and j.

Identification of multiple differential modules

To identify M-DM, we adapted the recently developed M-module algorithm (13) to analyze genes in each DCN. It was generally divided in three steps, as described in the following.

Seed prioritization

For each network G = (V, E) (1≤k≤M) with an adjacency matrix A= (aij)nxn, we applied a function to calculate the importance of gene i in the corresponding network, where N(i) denotes the set of neighbors of gene i in G; A′ denotes the degree normalized weighted adjacency matrix A′=D−1/2AD1/2 where D is the diagonal matrix of A. For each gene in DCN, after ranking genes according to the mean value of z-score, we selected the top 1% genes as the seed genes. Finally, 45 seed genes were obtained.

Module search by seed expansion

For an indicated gene v ∊ V, it was considered as a differential module C. The neighbors of gene i in the network was added to the module, generating a new module C′. Then we calculated the entropy for the connectivity of vertex i to C using the formula, where Lk(i) denotes total weight between gene i and other gene in the module C of network Gk. LK(i) denotes the weight between gene i and genes outside of module C. The entropy for C across all networks and normalized for the size of C is The connectivity variability between moule C and C′ was calculated according to H (C′,C)=H(C′)-H(C). If H (C′,C)>0, the gene u increased connectivity of module C. Then the neighbor genes which may increase H were added to the module C.

Refinement of candidate modules

The M-modules with a size less than five were removed. Overlapping M-modules with a Jaccard index more than 0.5 were merged to one module. Finally, 38 candidate modules were identified.

Statistical significance of M-DMs

The statistical significance test was performed using the null score distribution of M-DMs. Randomly selected 16,813 from 166,370 edges and constructed a random network. After 100 times random construction, 5,154 modules were obtained. The empirical P-value of an M-DM was defined as the probability of the module having the observed score or smaller by chance. After corrected by Benjamini and Hochberg (22), an adjusted P-value <0.05 was considered to indicate a statistically significant difference. In total, 17 modules with P<0.05 were identified as significant differential modules in each group.

Quantification of connectivity dynamics of shared M-DMs

Each M-DM with M >2 has multiple component modules from different DCNs. The Module Connectivity Dynamic Score (MCDS) was applied to quantify the change in the connectivity of component modules. For a given M-DM C whose adjacent matrices are denoted as where ||·||2 is the matrix L2 norm. τ(AC) denotes the overall MCDS of an M-DM. The statistical analysis is computed in similar way with that in M-DMs in Procedure 2.4. An adjusted P-value <0.05 was considered to indicate a statistically significant difference.

Enrichment analysis of M-DMs

Gene Ontology enrichment analysis

GO is a useful tool for collecting a large number of gene annotation terms (23). P=0.01 was considered as a threshold value. Genes in M-DMs were enriched to GO category according to Biological Process function. After enrichment analysis, two significant modules were obtained, module 1 indicating PES and module 2 indicating BMS group.

Pathway enrichment analysis

Pathways were obtained from Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database (http://www.genome.jp/kegg/). Fisher's exact test was applied to identify pathways in the differential modules. The pathways with adjusted P<0.05 were considered the enriched pathways in differential modules.

Results

DCNs construction

With the PPI data and microarray data, we selected the intersection set to construct DCNs using the edges at the criteria of Pearson's correlation coefficient >0.95. Two DCNs were obtained, with the same node set but different edge set, module 1 indicating PES and module 2 indicating BMS group.

M-DM construction

Genes were calculated for the importance in DCNs. Based on the average of z-scores, the top 1% genes were selected as seed genes, in total 45 seed genes, of which eight genes were found with average scores >400, as shown in Table I.
Table I.

Seed genes were identified with average z-score >400.

Nodez-score 1z-score 2Average
CUL31069.576978.97981024.278
APP851.2247829.1976840.2112
STAU1588.7511609.4044599.0777
SYNCRIP619.3264523.9833571.6549
CUL7395.7259648.4051522.0655
CUL4B401.4574602.1461501.8017
HNRNPR470.2798346.0184408.1491
HSPA9405.5541407.5701406.5621
With these seed genes, we performed module search and refinement, generating 38 modules. After statistical analysis, 17 candidate differential modules were obtained with adjusted P<0.05. Then connectivity dynamics of M-DMs were quantified using MCDS. At an MCDS P-value cut-off of 0.05, two M-DMs were identified with a major change of connectivity (Table II). In module 1 (PES group), there were 142 nodes and 460 edges (Fig. 1). In module 2 (BMS group), there were 73 nodes and 222 edges (Fig. 2).
Table II.

Two M-DMs were identified with a major change of connectivity.

Adjusted P-value

ModuleSeed geneEntropyMCDSEntropyMCDS
1CUL70.7669050.20721100.034
2CUL4B0.7434260.27796800.0069

M-MD, multiple differential module; MCDS, module connectivity dynamic score.

Figure 1.

Module 1 identified in paclitaxel-eluting stent group. It includes 142 nodes and 460 edges. PES, paclitaxel-eluting stent.

Figure 2.

Module 2 identified in BMS group. It includes 73 nodes and 222 edges. BMS, bare-metal stents.

GO enrichment analysis

At the P-value cut-off of 0.05, the enrichment of M-DMs genes in the GO biological process was obtained. In module 1, the top 20 significant biological processes are presented in Fig. 3, of which RNA processing was the most significant enrichment of biological process and primary metabolic process was the highest enrichment of biological process. In module 2, the top 20 significant biological processes were presented in Fig. 4, of which nucleic acid metabolic was the most significant enrichment of biological and metabolic was the highest enrichment of biological process.
Figure 3.

The top 20 significant biological processes obtained in module 1.

Figure 4.

The top 20 significant biological processes obtained in module 2.

Following the KEGG pathway enrichment analysis for genes from M-DMs, significant KEGG terms were collected. In module 1, five significant pathways are identified, and Spliceosome pathway was the most significant enrichment of genes (Table III). In module 2, nine pathways were identified with adjusted P<0.05, and Ubiquitin mediated proteolysis pathway was the most significant enrichment of genes (Table IV).
Table III.

KEGG pathway enrichment in module 1.

PathwaysP-valueAdjusted P-valueGenes
Spliceosome (PATH: hsa03040)1.84E-102.50E-08ALYREF, DDX42, HNRNPA3, DHX15, EFTUD2, EIF4A3, HNRNPC, SF3A1, SF3B2, SF3B3, DDX23 SNRNP70, RBM25, SNRPB
Pathogenic Escherichia coli infection (PATH: hsa05130)2.53E-060.000171848EZR, KRT18, TUBA1B, TUBA4A, TUBB6 TUBB4B, YWHAZ,
One carbon pool by folate (PATH: hsa00670)6.64E-050.003011209ATIC, GART, MTHFD1, SHMT2
Non-homologous end-joining (PATH: hsa03450)0.0003775290.012835974MRE11A, RAD50, XRCC5
Phagosome0.0017907180.048707539DYNC1H1, HLA-C, TFRC, TUBB6
(PATH: hsa04145)TUBA1B, TUBA4A, TUBB4B

KEGG, Kyoto Encyclopedia of Genes and Genomes.

Table IV.

KEGG pathway enrichment analysis in module 2.

PathwaysP-valueAdjusted P-valueGenes
Ubiquitin mediated proteolysis (PATH: hsa04120)1.55E-050.001720119CUL2, CUL3, CUL4A, CUL4B, MDM2, RFWD2, RNF7
Spliceosome (PATH: hsa03040)0.0001285250.00713315DHX15, HNRNPA3, SNRPB, SNRPD1, SNRPD3, SNRPG
Pathogenic Escherichia coli infection (PATH: hsa05130)0.0003198910.011835952TUBA1C, TUBA4A, TUBB, TUBB4B
p53 signaling pathway (PATH: hsa04115)0.0007214880.017621689CCNE1, MDM2, RFWD2, TP53
Herpes simplex infection (PATH: hsa05168)0.000793770.017621689C1QBP, CSNK2A2, TP53, POLR2A, NFKB1, USP7
Epstein-Barr virus infection (PATH: hsa05169)0.0012549440.023216458CSNK2A2, MDM2, TP53, POLR2A, NFKB1, USP7
Gap junction (PATH: hsa04540)0.0019729150.0273742TUBA1C, TUBA4A, TUBB, TUBB4B
Prostate cancer (PATH: hsa05215)0.0019729150.0273742CCNE1, MDM2, TP53, NFKB1
Nucleotide excision repair (PATH: hsa03420)0.0028025810.034565169CUL4A, CUL4B, ERCC6

KEGG, Kyoto Encyclopedia of Genes and Genomes.

Discussion

BMS and DES are frequently used in medicine (2). The use of DES has been shown more effective than BMS in the reduction of restenosis (4). In the present study, we aimed to compare the putative molecular mechanism induced by PES and BES in denuded human LIMA arteries. We applied M-module algorithm to identify differential modules. Compared with control samples, in each stent group, one differential module was identified, named as module 1 (PES) and module 2 (BES). The modules shared the same genes but with different interactions. After GO enrichment analysis, RNA processing was the most significant enrichment of biological process in module 1 and nucleic acid metabolic process was the most significant enrichment of biological process in module 2. Following the KEGG pathway enrichment analysis, five significant pathways were identified in module 1 and nine significant pathways were identified in 2. These identified significant modules and pathways may reveal potential molecular mechanisms between PES and BES in denuded human LIMA arteries. In the coronary artery lesions, DES have successfully decreased the rate of in-stent restenosis and target lesion revascularization compared with BMS (4,24). The amount of NIH at 6 months after stent implantation was significantly smaller in the PES than that identified than in the BMS group (25). While in the present study, we tried to explore the molecular differences between the two groups by identifying differential co-expressed networks. Changes in the structure and activity of gene network play a critical role in the disease progression. In the present study, we applied iMDM algorithm to explore differential co-expressed modules. This iMDM algorithm has been used in the time-course RNA-Seq dataset generated using a murine heart failure model generated on two genotypes (13), which achieved higher accuracy in inferring gene modules compared to using single or multiple co-expression networks. This method showed better performance in quantifying genes and edges in a module compared with traditional studies, such as hub genes, which only focused on highly connected genes in a pathway (26,27). With this method, two modules were identified after comparing stent-treatment samples to control samples. Different significant biological processes and KEGG pathways were found in these modules, indicating that PES and BMS induced different molecular changes in human LIMA arteries. There are some limitations in this study. The number of samples were too small in the study. That is not sufficient to obtain a conclusion. Still, the PES is rarely used in US due to the superiority of second-generation stents (zotarolimus- and everolimus-eluting stents), thus we will perform further analysis of second-generation stents. In conclusion, each stent-treated group was identified with a module, and different significant biological processes and different significant pathways were mediated by the two stent types. Thus through these modules, we revealed the potential molecular changes induced by PES and BMS, which provide new insights into the underlying mechanisms in human LIMA arteries after inserted with a stent.
  26 in total

1.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

2.  Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

Authors:  Gerrit J Laarman; Maarten J Suttorp; Maurits T Dirksen; Loek van Heerebeek; Ferdinand Kiemeneij; Ton Slagboom; L Ron van der Wieken; Jan G P Tijssen; Benno J Rensing; Mark Patterson
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

Review 3.  Coronary-artery stents.

Authors:  Patrick W Serruys; Michael J B Kutryk; Andrew T L Ong
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

4.  Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids.

Authors:  Peter S Gargalovic; Minori Imura; Bin Zhang; Nima M Gharavi; Michael J Clark; Joanne Pagnon; Wen-Pin Yang; Aiqing He; Amy Truong; Shilpa Patel; Stanley F Nelson; Steve Horvath; Judith A Berliner; Todd G Kirchgessner; Aldons J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

Review 5.  Intracoronary stenting. From concept to custom.

Authors:  P N Ruygrok; P W Serruys
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

6.  Effect of bare-metal nitinol stent implantation and paclitaxel-eluting nitinol stent implantation on vascular response in the superficial femoral artery lesion assessed on intravascular ultrasound.

Authors:  Kojiro Miki; Kenichi Fujii; Daizo Kawasaki; Masashi Fukunaga; Machiko Nishimura; Tetsuo Horimatsu; Ten Saita; Hiroto Tamaru; Takahiro Imanaka; Masahiko Shibuya; Motomaru Masutani; Mitsumasa Ohyanagi; Tohru Masuyama
Journal:  Circ J       Date:  2014-04-09       Impact factor: 2.993

7.  Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.

Authors:  Kaare H Bønaa; Jan Mannsverk; Rune Wiseth; Lars Aaberge; Yngvar Myreng; Ottar Nygård; Dennis W Nilsen; Nils-Einar Kløw; Michael Uchto; Thor Trovik; Bjørn Bendz; Sindre Stavnes; Reidar Bjørnerheim; Alf-Inge Larsen; Morten Slette; Terje Steigen; Ole J Jakobsen; Øyvind Bleie; Eigil Fossum; Tove A Hanssen; Øystein Dahl-Eriksen; Inger Njølstad; Knut Rasmussen; Tom Wilsgaard; Jan E Nordrehaug
Journal:  N Engl J Med       Date:  2016-08-29       Impact factor: 91.245

8.  Meta-analysis and profiling of cardiac expression modules.

Authors:  Uri David Akavia; Dafna Benayahu
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

9.  Network modeling links breast cancer susceptibility and centrosome dysfunction.

Authors:  Miguel Angel Pujana; Jing-Dong J Han; Lea M Starita; Kristen N Stevens; Muneesh Tewari; Jin Sook Ahn; Gad Rennert; Víctor Moreno; Tomas Kirchhoff; Bert Gold; Volker Assmann; Wael M Elshamy; Jean-François Rual; Douglas Levine; Laura S Rozek; Rebecca S Gelman; Kristin C Gunsalus; Roger A Greenberg; Bijan Sobhian; Nicolas Bertin; Kavitha Venkatesan; Nono Ayivi-Guedehoussou; Xavier Solé; Pilar Hernández; Conxi Lázaro; Katherine L Nathanson; Barbara L Weber; Michael E Cusick; David E Hill; Kenneth Offit; David M Livingston; Stephen B Gruber; Jeffrey D Parvin; Marc Vidal
Journal:  Nat Genet       Date:  2007-10-07       Impact factor: 38.330

10.  Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesis.

Authors:  Franco J Vizeacoumar; Nydia van Dyk; Frederick S Vizeacoumar; Vincent Cheung; Jingjing Li; Yaroslav Sydorskyy; Nicolle Case; Zhijian Li; Alessandro Datti; Corey Nislow; Brian Raught; Zhaolei Zhang; Brendan Frey; Kerry Bloom; Charles Boone; Brenda J Andrews
Journal:  J Cell Biol       Date:  2010-01-11       Impact factor: 10.539

View more
  1 in total

1.  Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension.

Authors:  Fawad Ali; Arifullah Khan; Syed Aun Muhammad; Syed Qamar Abbas; Syed Shams Ul Hassan; Simona Bungau
Journal:  ACS Omega       Date:  2022-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.